Dr. Paul, Rep. Finstad Introduce Resolution to Repeal Harmful FDA Rule Limiting Access to Laboratory Developed Tests
May 17, 2024
May 17, 2024
WASHINGTON, May 17 -- Sen. Rand Paul, R-Kentucky, issued the following news release:
On Wednesday, U.S. Senator Rand Paul (R-KY) introduced a resolution under the Congressional Review Act (CRA) to repeal Medical Devices: Laboratory Developed Tests (LDTs), a rule that was recently finalized by the Food and Drug Administration (FDA). The final rule, published May 6th, seeks to impose burdensome regulations on the creation and implementation of laboratory developed tests (LDTs), limiti . . .
On Wednesday, U.S. Senator Rand Paul (R-KY) introduced a resolution under the Congressional Review Act (CRA) to repeal Medical Devices: Laboratory Developed Tests (LDTs), a rule that was recently finalized by the Food and Drug Administration (FDA). The final rule, published May 6th, seeks to impose burdensome regulations on the creation and implementation of laboratory developed tests (LDTs), limiti . . .